KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Globus Medical (GMED) Restructuring Costs (2016 - 2025)

Globus Medical (GMED) has disclosed Restructuring Costs for 11 consecutive years, with $10.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Restructuring Costs fell 36.65% year-over-year to $10.8 million, compared with a TTM value of $42.3 million through Dec 2025, up 42.88%, and an annual FY2025 reading of $42.3 million, up 42.88% over the prior year.
  • Restructuring Costs was $10.8 million for Q4 2025 at Globus Medical, up from -$2.7 million in the prior quarter.
  • Across five years, Restructuring Costs topped out at $45.6 million in Q3 2023 and bottomed at -$3.6 million in Q3 2024.
  • Average Restructuring Costs over 5 years is $8.0 million, with a median of $2.4 million recorded in 2021.
  • The sharpest move saw Restructuring Costs soared 24667.86% in 2021, then plummeted 207.77% in 2022.
  • Year by year, Restructuring Costs stood at $2.5 million in 2021, then soared by 46.06% to $3.6 million in 2022, then soared by 330.65% to $15.6 million in 2023, then rose by 9.67% to $17.1 million in 2024, then crashed by 36.65% to $10.8 million in 2025.
  • Business Quant data shows Restructuring Costs for GMED at $10.8 million in Q4 2025, -$2.7 million in Q3 2025, and $33.2 million in Q2 2025.